Dashboard
Manage Tickers

LIXTLIXTE BIOTECHNOLOGY HOLDING...

Nasdaq lixte.com


$ 2.04 $ 0.01 (0.58 %)    

Monday, 19-Aug-2024 14:11:20 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 480.10 $ -1.20 (-0.25 %)
DIA $ 408.49 $ -0.40 (-0.1 %)
SPY $ 558.39 $ -0.77 (-0.14 %)
TLT $ 98.59 $ 0.29 (0.3 %)
GLD $ 231.71 $ -2.01 (-0.86 %)
$ 2.0116
$ 1.96 x 100
-- x --
-- - --
$ 1.58 - $ 4.42
10,431
na
4.52M
$ 0.72
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 03-19-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-09-2023 06-30-2023 10-Q
6 05-10-2023 03-31-2023 10-Q
7 03-29-2023 12-31-2022 10-K
8 11-08-2022 09-30-2022 10-Q
9 08-10-2022 06-30-2022 10-Q
10 05-11-2022 03-31-2022 10-Q
11 03-21-2022 12-31-2021 10-K
12 11-10-2021 09-30-2021 10-Q
13 08-10-2021 06-30-2021 10-Q
14 05-12-2021 03-31-2021 10-Q
15 03-26-2021 12-31-2020 10-K
16 11-10-2020 09-30-2020 10-Q
17 08-10-2020 06-30-2020 10-Q
18 05-11-2020 03-31-2020 10-Q
19 03-25-2020 12-31-2019 10-K
20 11-08-2019 09-30-2019 10-Q
21 08-06-2019 06-30-2019 10-Q
22 05-09-2019 03-31-2019 10-Q
23 03-25-2019 12-31-2018 10-K
24 11-08-2018 09-30-2018 10-Q
25 08-02-2018 06-30-2018 10-Q
26 04-27-2018 03-31-2018 10-Q
27 03-23-2018 12-31-2017 10-K
28 11-09-2017 09-30-2017 10-Q
29 08-04-2017 06-30-2017 10-Q
30 05-10-2017 03-31-2017 10-Q
31 03-29-2017 12-31-2016 10-K
32 11-04-2016 09-30-2016 10-Q
33 08-10-2016 06-30-2016 10-Q
34 05-06-2016 03-31-2016 10-Q
35 03-28-2016 12-31-2015 10-K
36 11-10-2015 09-30-2015 10-Q
37 08-07-2015 06-30-2015 10-Q
38 05-13-2015 03-31-2015 10-Q
39 03-27-2015 12-31-2014 10-K
40 11-12-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

lixte-biotechnology-provides-update-on-recent-activities-and-developments-collaboration-with-nki-and-funding-support-for-new-colorectal-cancer-clinical-trial-by-major-pharma-co-preclinical-data-published-in-journal-embo-reports-shows-lb-100-as-potentially-enhancing-the-benefit-of-immunotherapy
LIXTE Biotechnology Provides Update On Rec...
08/19/2024 12:42:43

-Collaboration with NKI and Funding Support for New Colorectal Cancer Clinical Trial by Major Pharma Company--Distinguished Onc...

Core News & Articles
LIXTE Biotechnology Announces Collaboratio...
06/14/2024 13:31:51

lixte-biotechnology-shares-are-trading-higher-after-the-company-announced-the-publication-of-pre-clinical-data-in-the-journal-embo-reports-showing-that-lb-100-increases-recognition-of-colon-cancer-cells-by-the-immune-system
LIXTE Biotechnology shares are trading hig...
06/06/2024 12:37:39

lixte-biotechnology-announced-publication-of-data-in-embo-reports-showing-lb-100-increases-recognition-of-colon-cancer-cells-by-immune-system
LIXTE Biotechnology Announced Publication ...
06/06/2024 12:36:01

LB-100 Generates Neo-Antigens in Cancer Cells that are Presented to the Immune Systemby Disrupting the Process of RNA Splicing

lixte-biotechnology-granted-european-patent-for-oxabicycloheptane-prodrugs-for-use-in-treating-cancer
Lixte Biotechnology Granted European Paten...
06/03/2024 17:11:06

https://register.epo.org/application?number=EP20167812

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
05/17/2024 20:31:00

lixte-biotechnology-holdings-files-50m-offering
Lixte Biotechnology Holdings Files $50M Of...
04/23/2024 17:50:43

-SEC Filing

watching-lixte-biotechnology-white-diamond-research-posts-on-x-breaking-news-lixte-biotechnology-lied-its-publication-yesterday-isnt-new--its-the-same-one-they-published-over-a-year-ago
Watching Lixte Biotechnology; White Diamon...
03/28/2024 15:38:19

White Diamond on X: "BREAKING NEWS: Lixte Biotechnology Lied: Its Publication Yesterday Isn't New – It's The Same O...

gold-moves-higher-velo3d-shares-plummet
Gold Moves Higher; Velo3D Shares Plummet
03/27/2024 19:24:50

U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones index gaining over 300 points on Wednesday. The...

why-luxurban-hotels-shares-are-trading-lower-by-around-27-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why LuxUrban Hotels Shares Are Trading Low...
03/27/2024 17:06:58

Shares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary fo...

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
03/27/2024 16:31:07

crude-oil-edges-lower-paysign-shares-spike-higher
Crude Oil Edges Lower; PaySign Shares Spik...
03/27/2024 16:00:06

U.S. stocks traded mostly higher midway through trading, with the Dow Jones gaining over 200 points on Wednesday. The Dow trad...

why-lixte-biotechnology-stock-is-soaring
Why Lixte Biotechnology Stock Is Soaring
03/27/2024 14:56:25

The company announced the publication of pre-clinical data in the online journal, "Cancer Discovery", showing that its ...

dow-jumps-over-200-points-unifirst-posts-downbeat-earnings
Dow Jumps Over 200 Points; UniFirst Posts ...
03/27/2024 13:39:35

U.S. stocks traded higher this morning, with the Dow Jones gaining over 200 points on Wednesday. Following the market opening ...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
03/27/2024 13:05:57

lixte-biotechnology-holdings-publication-pre-clinical-data-in-cancer-discovery-regarding-lb-100
LIXTE Biotechnology Holdings Publication P...
03/27/2024 12:37:11

LB-100 IS SYNERGISTIC WITH WEE1 INHIBITION IN KILLING CANCER CELLS; FINDING OPENS NEW TREATMENT STRATEGY IN ADDITION TO THREE C...

lixte-provides-update-on-progress-with-lb-100-as-a-pp2a-inhibitor-to-enhance-chemotherapy-and-immunotherapy-cancer-treatments
LIXTE Provides Update On Progress With LB-...
03/21/2024 12:35:48

-- Three Clinical Trials Currently Underway for Treating Ovarian, Lung and Sarcoma Cancers --PASADENA, Calif., March 21, 2024 (...

lixte-biotechnology-announces-presentation-of-pre-clinical-data-on-lixtes-lb-100-at-joint-conference-of-european-and-american-associations-for-cancer-research
LIXTE Biotechnology Announces Presentation...
02/27/2024 13:36:57

Conference In Dublin, Ireland on February 27 - 29, 2024Focuses on How to Bring Basic Science Discoveries to the Clinic

lixte-biotechnology-enters-exclusive-immune-oncology-patent-license-agreement-with-ninds-and-nci
LIXTE Biotechnology Enters Exclusive Immun...
02/26/2024 13:34:00

Core News & Articles
Lixte Biotechnology Announces Dosing Of Fi...
01/29/2024 13:41:14

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION